Research Article
Investigation of the Clinical Significance and Prognostic Value of the lncRNA ACVR2B-As1 in Liver Cancer
Table 1
Clinical characteristic of the included patients.
| | Characteristics | Number of pts (%) |
| | Age | | <55 | 117 (31.62) | | ≥55 | 253 (68.38) | | NA | 1 (0) |
| | Gender | | Female | 121 (32.61) | | Male | 250 (67.39) |
| | Histological type | | | Fibrolamellar carcinoma | 3 (0.81) | | Hepatocellular carcinoma | 361 (97.3) | | Hepatocholangiocarcinoma | 7 (1.89) |
| | Histologic grade | | G1 | 55 (14.82) | | G2 | 177 (47.71) | | G3 | 122 (32.88) | | G4 | 12 (3.23) | | NA | 5 (1.35) |
| | Stage | | I | 171 (46.09) | | II | 86 (23.18) | | III | 85 (22.91) | | IV | 5 (1.35) | | NA | 24 (6.47) |
| | T classification | | T1 | 181 (48.79) | | T2 | 94 (25.34) | | T3 | 80 (21.56) | | T4 | 13 (3.5) | | TX | 1 (0.27) | | NA | 2 (0.54) |
| | N classification | | N0 | 252 (67.92) | | N1 | 4 (1.08) | | NX | 114 (30.73) | | NA | 1 (0.27) |
| | M classification | | M0 | 266 (71.7) | | M1 | 4 (1.08) | | MX | 101 (27.22) |
| | Radiation therapy | | No | 338 (91.11) | | Yes | 8 (2.16) | | NA | 25 (6.74) |
| | Residual tumor | | R0 | 324 (87.33) | | R1 | 17 (4.58) | | R2 | 1 (0.27) | | RX | 22 (5.93) | | NA | 7 (1.89) |
| | Vital status | | Deceased | 130 (35.04) | | Living | 241 (64.96) |
| | Relapse | | No | 179 (48.25) | | Yes | 139 (37.47) | | NA | 53 (14.29) |
| | ACVR2B-AS1 | | High | 211 (56.87) | | Low | 160 (43.13) |
|
|
